Background: The Overlooked Vitamin
Before a breast cancer patient enters the operating room, a standard checklist covers heart function, blood count, and allergies—but rarely vitamin D. Researchers at Fayoum University in Egypt investigated what that omission might mean for recovery.
Study Design: A Controlled Trial with 184 Patients
The study ran at the university hospital from September 2024 to April 2025, enrolling 184 patients scheduled for mastectomy. Half had vitamin D levels below the deficiency threshold; the other half were above. Age, surgical plan, and baseline health were matched between groups. All patients received the same pain management: fentanyl during surgery, intravenous acetaminophen on schedule, and patient-controlled tramadol via a pump.
Key Findings: Increased Pain and Opioid Use
The primary endpoint was postoperative pain at 12 hours (0-10 scale). Patients in the deficient group were roughly three times more likely to have a pain score above 3 compared to those with sufficient levels. None reported severe pain (≥7); the gap appeared in the moderate pain range (4-6). Deficient patients used an average of 112 mg more tramadol in the first day. Nausea was more common in the deficient group, consistent with higher opioid burden.
Potential Mechanism: Inflammatory Pathways
Vitamin D is thought to dampen pain sensitivity by reducing inflammatory signals in injured tissue. Previous studies have linked low vitamin D to higher pain in chronic back pain and gallbladder surgery, but this is the first to measure the relationship specifically in breast cancer patients.
Limitations and Future Directions
The team acknowledges this observational study shows correlation, not causation. Mental health, cancer stage, prior treatments, and sleep quality were not analyzed, and inflammatory markers were not measured. Nevertheless, vitamin D testing is cheap, fast, and routine. If confirmed by clinical trials, preoperative vitamin D supplementation could become part of standard preparation for breast cancer surgery, potentially reducing pain and opioid use.